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ABSTRACT 
Cassia fistula Linn. is also called a “golden shower”. It is aboriginal to India, Sri Lanka and diffused in various countries, including Mexico, China, 
Mauritius, East Africa, South Africa, and West Indies. Plant and its parts, such as bark, fruit, leaves, and seeds, are used traditionally to cure diseases. 
Traditionally the plant possesses hepatoprotective, antipyretic, anti-inflammatory, leukotriene inhibition, antitussive activity, antioxidant, wound 
healing, hypo-lipidemia, anticancer, antidiabetic, central nervous system activity, antiulcer, antibacterial, antifertility, larvicidal and ovicidal, 
antifeedant, laxative, anti-epileptic, antimicrobial, urease inhibition, antifungal, anti-tobacco mosaic virus activities. The review contains botanical 
information, constituents and pharmacological leverages of the plant. The review draws attention towards the traditional, phytochemical and 
pharmacological knowledge accessible on Cassia fistula Linn, which would be beneficial for research scholars to develop novel chemical entities. 
This review article is written after studying most of the journal’s articles, which were published between 1998 to 2019. 
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INTRODUCTION 
Since long the extracts of plants are used to relieve the symptoms of 
many diseases [1]. Most of the herbal drugs are not critically examined 
because herbs are assumed that they are safe and natural but many 
herbs have serious adverse effects, which might create life-threatening 
conditions [2]. The main objective of this review is to highlight the 
botanical reports, pharmacological uses, and toxicity studies. Cassia 
fistula is a deciduous-mixed monsoon forest tree species having an 
approximate height of 24 m and 1.8 m girth that belongs to the 
Fabaceae family (this family includes a large number of about 670 
genera and nearly 20,000 plant species). It is famed as Amulthus, 
“Golden Shower” and also popularized as “Indiana Laburnum”. This 
plant species confers huge ethnomedicinal importance and has 
extensively been used in Ayurveda to cure many diseases. It is native 
to India, Sri Lanka and diffused in various countries, including Mexico, 
China, Mauritius, East Africa, South Africa, and West Indies [3, 4]. It is a 
Thailand national tree. It grows in the shade and develops in low 
supplement and shallow soil. Seeds and Vegetative means are the two 
methods for germination [5]. A young tree's bark color is greenish-
grey and it becomes dark brown colored after maturing. It is a tree that 
lasts for a short time. Leaves consist of leaflets that pair 2-5 cm long 
and contain about 3-8 reverse frill duets. Flowers of golden shower 
trees are golden yellow in color and showers flower bunches of length 
40 cm [6-8]. Cassia fistula has been used in folk medicine and reported 
for various pharmacological properties. Every part of this plant is 
recognized for its medicinal properties.  
Botanical reports of Cassia fistula Linn. 
Kingdom: Plantae, Subkingdom: Tracheobinota, Superdivision: 
Spermatophyta, Division: Magnoliophyta, Class: Magnoliopsida, 
Subclass: Rosidae, Order: Fabales, Family: Fabaceae, Genus: Cassia, 
Species: fistula [9].  
Vernacular names of Cassia fistula Linn. 
Cassia fistula is also recognized by some other names in different 
languages and regions. 
 
Table 1: Vernacular names of Cassia fistula Linn 
 Vernacular names 
 Guajarati: Garmala [10] 
 Bengali: Bundaralati, Soondali, Sonalu [10] 
 Hindi: Amultus, Sonhali [10] 
 Punjabi: Kaniyaar, Girdnalee, Amaltaas [10] 
 English: Golden Shower [10] 
 Tamil: Shrakkonnai, Irjviruttam [10] 
 Marathi: Bahava [10] 
 Kannad: Kakkemara [10] 
 Arab: Khayarsambhar [10] 
 Telegu: Raelachettu, Aragvadhamu [10]  
 Oriya: Sunaari [10] 
 Urdu: Amaltaas [10] 
 Sanskrit: Nripadruma [10] 
 French: Douche d’or [11] 
 Malaysia: Kayu raja [11] 
 Sri Lanka: Aehaela-gaha [11] 
 Germany: Fistul-kassie [11] 
 Thailand: Chaiyaphruek [11] 
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Table 2: Chemical constituents of various parts Cassia fistula plant 
Plant parts Constituents 
Bark The stem bark contains lupeol, ß-sitosterol, and hexacosanol [12]. 
Leaves Leaves contain heptacosanyl-5-hydroxypentadec-2-enoate, octacosan-5, and 8-diol [13]. Rhein, chrysophanol, and physcion [14]. 
Pod The pod contains rhein glycoside and ferulic acid, ceryl alcohol, anthraquinone, and tannin [15, 16]. 
Flowers Flowers contain kaempferol, leucopelargonidin tetramer, rhein, fistulin, and triterpene [17]. 
Seeds Seeds contain glycerides with linoleic, oleic, stearic, and palmitic acids as chief fatty acids and traces of caprylic and myristic acids [18]. 
others: 5-(2-hydroxy phenoxy methyl)furfural, (2's)-7-hydroxy-5-hydroxymethyl-2-(2'-hydroxypropyl) chromone, benzyl 2-hydroxy-3, 
6-dimethoxybenzoate, and benzyl 2 β-o-d-glucopyranosyl-3, 6-dimethoxybenzoate together with other compounds, (2's)-7-hydroxy-2-
(2'-hydroxypropyl)-5-methylchromone, and two oxyanthraquinones, chrysophanol, and chrysophaneinhanein [19]. 
Galactomannan [20]. 
 
Pharmacological activities of Cassia fistula linn 
The plant Cassia fistula has a broad variety of pharmacological 
activities. A lot of research has been done on this plant for many 
years. This plant is easily available in many regions. Cassia fistula 
and its derivatives are considered as an important source of active 
ingredients that can be used in drug development. 
 












Leaves n-heptane Paracetamol  400 mg/kg  Wistar albino rats 
180-200 g 
Dropping the serum levels of transaminases, 
bilirubin and alkaline phosphatase. 
[21] 
Roots  Alcoholic  CCl4 100, and 200 
mg/kg 
Wistar albino rats 
170-200 g 





Ethanolic  CCl4 500 mg/kg  Rats  Ethanolic leaf extract reverses lipid 
peroxidation. 
It also reverses the activities of catalase and 





Aqueous  CCl4  Albino Wistar rats 
180-200 g. 
Reduced plasma enzyme and bilirubin 
concentration in rats. 
[24] 
Seeds  Methano 
lic  
Paracetamol  200, and 400 
mg/kg 







Methanolic  Yeast  250, and 500 
mg/kg 
Wistar rats 200-
220 g and  
Swiss albino mice 
18-25 g 
Improved hypothermal activity. [26] 
Pod   Yeast 200, and 400 
mg/kg 












250, 500 mg/kg 
50, 100, 250, 500, 
and 750 
mg/kg 
Wistar albino rat  
180-200 g 
 
It helps in reducing body temperature. 






Fruits  Methanolic     Inhibition of the 5-lipoxygenase enzyme. [28] 
Antitussiv
e  
Leaf  Methanolic Sulphur dioxide 
gas 
400, 600 mg/kg White albino mice 
30-40 g  























used between 50 
to 5000  
In vitro Ethanolic extract showed 90% protection of 
erythrocytes. 
An aqueous extract showed 75% of antioxidant 







Methanolic   In vitro Bark extracts from three different age classes 
showed high antioxidant activity than other 








Bark  Aqueous 
and 
Methanolic  
CCl4 and FeSO4 
 
 In vitro 
Wistar albino rats 
 
 Both extracts show significant antioxidant 
activity in DPPH, Nitric oxide and Hydroxyl 
radical 
The significant anti-inflammatory effect in both 






Bark Ethyl acetate  
Methanolic  
n-hexane  
  In vitro Antioxidant activity of Ethyl acetate extract, 
methanol extract, and n-hexane extract is 
65.98%, 58.19%, and 32.66%, respectively. 
[34] 
Pods n-hexane  
Ethyl acetate  
Aqueous 
fractions  
  In vitro Antioxidant potency was found to be in decreasi
ng order of ethyl acetate  
>n-hexane>aqueous fractions, and had good co-
relationship with Their 
polyphenolic and flavonoid material. 
[35] 
Flowers Aqueous  Alloxan  10 ml/kg Female Wistar rats 
180-200 g 
In diabetic rats, decreased production of supero
xide dismutase, catalase, glutathione peroxidase,
 glutathione reductase and glutathione were bro




  In vitro Inhibiting DPPH and hydroxyl radical, total 
phenol content. 
[37] 
Anti- Flower  Carrageenan- Rhein 10, 20, 40 Wistar albino rats  Inhibited paw edema. [38] 
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20, 40 mg/kg 
10, 20 and 40 
mg/kg 
200-220 g and 
mice 24-28 g 
Inhibited ear edema in mice in dose-dependent 
manners. 
17.24% and 36.12% 
reduced granuloma formation  










dried pulp of 
Cassia fistula  
Water 
 
Carragenan 100, 200, 300, 400 








Wistar Albino rats 
150-300 g 
Solanum xanthocarpum Schrad and Wendl 
showed more activity than the dried fruits of 
Cassia fistula. 
Both extracts had maximum activity at 500 mg/
kg dose. 













200, 400, and 800 
mg/kg 
Male Wistar albino 
rats  
130-150 g 
Suppress the inflammation that carrageenan, his












 In sub-acute 
models 
Significant anti-inflammatory activity. [41] 
Wound 
Healing 
Bark  Hexane  Streptozotocin 
induced 
Diabetes 
0.15, 0.30, and 
0.45 g/kg 
Wistar albino Rats 
150-200 g 
























Significant prohealing activity. 
Effective wound closure, better tissue 
regeneration at the wound site and support for 
wound-related histopathological parameters. 
[43] 
 
 Leaves  Methanolic Excision and 
Incision  
5% and 10% w/w 
ointment  
Rats  Comparable results with standard medication, 
nitrofurazone in terms of wound contraction 
capacity, duration of epithelization, tensile 









100, 250, and 500 
mg/kg b. wt./day 
Rats   Specifically prevented the dose-dependent rise 
of serum total and LDL-cholesterol, 











100, 200, and 300 
mg/kg/day 
 
Male albino Swiss 
mice 18-22 g 
Increased lifespan and reduced tumor volume 




Flower  Aqueous  MCF-7 and 





In vitro  
 
AgNPs can be used in the development of novel 
anticancer drugs. 
90.5%, and 89.7% cell death was noticed in 
MCF-7 and Vero cell lines, respectively.  
The inhibitory concentration (IC50) against 






Ethyl acetate  Colon cancer 
cell lines. 
cell line such as 
COLO320DM 
Normal cell line 
VERO 
200 μg/ml In vitro Rhein showed 40.59%, 58.26%, 65.40%, 
77.92%, and 80.25% cytotoxicity at 200 μg/ml 












 CDRUG server to 
check the 
anticancer activity 
The results of our study clearly show that HOP-
22(29)-EN-3. BETA.-OL may serve as a 
promising inhibitor for cancer treatment and 









Streptozotocin 10, 30 mg/kg Male Wistar albino 
rats 160-180 g 
The decrease in blood glucose, cholesterol, and 


















200, 400 mg/kg Wistar rats of 
either sex  
150-180 g 
Appreciable results in a drop in the plasma 




Streptozotocin 60 mg/kg  Male albino Wistar 
rats 150-200 g  
Gold nano-particles with Cassia fistula have 
promising anti-diabetic properties. 
[52] 
[52] 
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Stem barks  
of Tamarind 






Alloxan 250, 500 mg/kg 
In vitro Different 
Doses 
Wistar rats  
150-200 g 
 
The combination has a lowering level of blood 
glucose along with antioxidant and defensive 
levels on renal complications. 
Both extracts showed promising free radical 
DPPH scavenging activity in a concentration-
dependent manner up to 250 μg/ml. Cassia 
fistula showed more scavenger behavior than 
Tamarindus indica.  
[53] 
 
Stem bark Methanol  Streptozotocin  Catechin20 mg/kg
  
 
Male albino wistar 
rats 
Results confirm that catechin has a 
hypoglycemic effect. We may infer that catechin 






Fruits Methanolic   in vitro activity of 
the isolated 
biochanin A 






Seed Methanolic Morphine and 
pethidine 
1, 1.66, and 2.5 
g/kg  
Swiss albino mice 
of either sex 20-25 
g  
Methanolic extract showed a significant CNS 
depressant action in a dose-dependent manner. 
[56] 
[56] 






250, 500, and 750 
mg/kg  
Rats  Decreased gastric acid secretion, protection of 
the mucosal barrier, and inhibition of free 
radical generation. 
Ethanolic leaf extract (750 mg/kg) produced 











A decline in the fertility index, dose-dependent 
numbers of uterine implants and live fetuses (100 
mg/kg) and poor estrogenic activity when 
administered alone 
[58] 
Seeds Aqueous   100 mg/kg 
200 mg/kg 
500 mg/kg  
Female rats Prevents pregnancy 57.14%  
71.43% pregnancy inhibition 






Leaf Methanolic   LC50 values of 
17.97 and 20.57 
mg/l, 






The extract was more lethal to the larvae of 
Anopheles stephensi than Culex quinquefasciatus 




Leaf    0.5, 1.0, and 2.0%, 
topically applied 
Eggs  Inhibited hatching of the eggs and increased extract 
concentration resulted in an improved abrogation 
















Considerable antifeedant activity against 
Helicoverpa armigera (76.13%) was observed. 
Rhein exhibited larvicidal activity against 
Helicoverpa armigera (67.5%), Spodoptera litura 
(36.25%) respectively. 
The survived larvae were malformed adults. 
[62] 
 Leaves of 




Piper nigrum  
Methanol  
 





In vitro  
Exhibited remarkable Adulticidal and Larvicidal 
potentials. 
Cassia fistula pod infusion could be safely 
utilized as laxative drugs and as a substitute for 

















 2.4, 3.6 g of 
decoction extract 
Rats  It shows the laxative property. [64] 
Anti-
epileptic  
Seeds Methanolic  Pentylenetetraz
ol (PTZ) 
100, 200 mg/kg Mice Methanolic extract of seeds of Cassia fistula 






Seeds   182.2 mg/g  Ni(II) ion adsorption system undergoes 
chemisorption, exothermic, feasible and 
spontaneous. The excellent properties of 
the Cassia fistula seeds can be alternate for 











  In vitro Ex. cept for chloroform extract, all four samples 















  In vitro Showed excellent anticandidal activity. Ethanol 
extract of Cassia fistula seed exhibited the most 

















Cassia fistula was the most potent inhibitor of 
Penicillium marneffei. 
The hyphal growth of Trichophyton rubrum, 
Microsporum gypseum, and Penicillium marneffei 











  In vitro Results showed that compounds 1 and 2 showed 
high Anti-tobacco mosaic virus activity with an 
inhibition rate of 28.5% and 31.3%. Compounds 
4-7 showed modest anti-Anti-tobacco mosaic 
virus activity with an inhibition rate of 18.5%, 
22.7%, 16.4%, and 15.3%, respectively. 
[70] 
 
Sanoria et al. 









  Dose-dependent 
(0, 10, 20, 40, and 
80 µg/ml 
 fruit extract showed a heightened bactericidal 
activity against  
Escherichia coli and Klebsiella pneumonia. 100% 
against former and 91% in the case of latter 
Gram-negative bacteria. AgNPs did not exhibit 



















  In vitro  The Plant protease inhibitor was found to be 
very active against Staphylococcus aureus, 







 5, 10, 20, 40, 80, 
and 160 mg/ml 
 
In vitro The most susceptible microorganisms to 
extracts were Escherichia coli and Klebsiella 
pneumoniae, respectively. 
Also, Bacillus cereus, and Staphylococcus 










 5, 25, 50, 100, 250 
μg/ml 
In vitro Results demonstrated strong inhibition of 
bacterial growth against the studied species. 





 5, 25, 50, 100, 250 
μg/ml 
In vitro Crude extracts showed moderate and strong 







d water  
 (5, 2.5, and 1.25 
mg per disc) with 
three replicates 
In vitro  Extracts of Cassia fistula flowers showed 
inhibition against “Gram-positive” bacteria. 










  In vitro   Results showed that the antibacterial activity of 
compound 1 was found to be fairly good against 
Gram+ve bacteria, and Gram-ve bacteria. The 
antifungal activity of compound 1>Aspergillus 









In vitro Results showed Antimicrobial activity and it was 




Table 4: Toxicity status of cassia fistula 
Solvent for extraction  Plant part  Results  Reference 
Aqueous  Pods Possessed very low levels of toxicity, having the LD50 of 6600 mg/kg and no  
Pathological effects on the organs. 
[79] 
Alcoholic  Stem bark No signs of toxicity up to a dose level of 2000 mg/p. o. [80] 
Aqueous and methanolic  Bark  Acute toxicity study with the extracts showed no sign of toxicity up to a dose 
level of 2000 mg/po. 
[81] 
Methanolic  Seeds Seeds extract with high LC50 value signified that this plant is not toxic to human [77] 
Ethanolic  Fruit  In acute studies: Cassia fistula extract up to a dose of 5000 mg/kg did not induce 
mortality and In sub-acute studies: showed Cassia fistula extract at the doses of 
250, 500 and 1000 mg/kg to rats did not induce mortality. 
[82] 
 
Toxicity status of cassia fistula linn 
Different toxicity studies have been done by researchers and they 
found that different parts of the plant are non-toxic or very less toxic 
to humans. 
CONCLUSION 
Cassia fistula Linn. has been examined scrupulously for its 
phytochemical and pharmacological activities. From the above 
review, it is concluded that Cassia fistula Linn. has been used as an 
important curative agent for patients. It is a very useful herbal plant 
and needs to explore more to know the exact mechanism. In both in 
vivo and in vitro studies, Cassia fistula has various pharmacological 
properties. 
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